Great Basin: Great Basin Scientific, Inc. (GBSN: OTCQB) | Great Basin Scientific Provides Business Update

Jun 26, 2017 OTC Disclosure & News Service - New Business Pipeline exceeds $5.0 million in potential new revenue; Nearly $2.0 million in potential pipeline revenue is from Stool Bacterial Pathogens Panel, currently awaiting FDA clearance SALT LAKE CITY, June 26, 2017 (GLOBE NEWSWIRE) - Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today provided [...]